These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 15599880)

  • 1. Rapidly progressive glomerulonephritis: current and evolving treatment strategies.
    Little MA; Pusey CD
    J Nephrol; 2004; 17 Suppl 8():S10-9. PubMed ID: 15599880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
    Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
    Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
    Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
    Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in treatment strategies for patients with antineutrophil cytoplasmic antibody-associated rapidly progressive glomerulonephritis.
    Hotta O; Ishida A; Kimura T; Taguma Y
    Ther Apher Dial; 2006 Oct; 10(5):390-5. PubMed ID: 17096692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapidly progressive glomerulonephritis.
    Erwig LP; Rees AJ
    J Nephrol; 1999; 12 Suppl 2():S111-9. PubMed ID: 10688410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Goodpasture's syndrome with neurologic involvement and negative ANCA].
    Pérez-Suárez G; Marrero D; Rodríguez R; Delgado P; Cobo M; González-Posada JM; Hernández D
    Nefrologia; 2010; 30(5):584-7. PubMed ID: 20613848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracapillary glomerulonephritis type I with the coexistence of positive anti-GBM and p-ANCA antibodies.
    Toledo Perdomo K; Ortega Salas R; Pérez-Sáez MJ; Esquivias de Motta E; Espinosa Hernández M; López Andreu M; López Rubio F; Aljama García P
    Nefrologia; 2011; 31(1):113-5. PubMed ID: 21270926
    [No Abstract]   [Full Text] [Related]  

  • 9. [Simultaneous presence of antibodies against the glomerular basement membrane and anti-myeloperoxidase antibodies in 2 patients with rapidly progressive glomerulonephritis].
    Díaz Rodríguez C; Costero O; Torre A; De Alvaro F; Gil F; Picazo ML; Martínez-Ara J
    Nefrologia; 2002; 22(2):190-5. PubMed ID: 12085420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early diagnosis of rapidly progressive glomerulonephritis].
    Maggiore U; Michelassi S; Farsi A; Maggiore Q
    Ann Ital Med Int; 1995; 10(4):227-32. PubMed ID: 8718657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and the therapeutic methods. Organ-specific autoimmune diseases. 5) Anti-GBM antibody diseases].
    Nagasawa T
    Nihon Rinsho; 1988 Apr; 46(4):918-24. PubMed ID: 3404713
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of ANCA-positive vasculitis with thyroid disease.
    Rothe HM; Siegmund J; Müller H; Wopperer J
    Nephrol Dial Transplant; 2008 Jun; 23(6):2107; author reply 2107-8. PubMed ID: 18323519
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of glomerular diseases: ANCA-negative RPGN.
    Bolton WK
    Semin Nephrol; 2000 May; 20(3):244-55. PubMed ID: 10855934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineutrophil cytoplasmic antibody (ANCA) and rapidly progressive crescentic glomerulonephritis in Thai population.
    Sumethkul V; Changsirikulchai S; Radinahamed P; Chalermsanyakorn P
    Asian Pac J Allergy Immunol; 1999 Dec; 17(4):281-7. PubMed ID: 10698468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange in the treatment of rapidly progressive glomerulonephritis.
    Chen X; Chen N
    Contrib Nephrol; 2013; 181():240-7. PubMed ID: 23689585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
    Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
    Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New strategies for plasma exchange in systemic vasculitis.
    Jayne DR
    Transfus Sci; 1990; 11(3-4):263-9. PubMed ID: 10149528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of Goodpasture syndrome positive for anti-GBM antibody and MPO-ANCA complicated by a variety of serious infections.
    Sakoda C; Kusaba T; Adachi T; Sonomura K; Kimura T; Nakayama M; Kishimoto N; Nakagawa H; Okigaki M; Hatta T; Matsubara H; Mori Y
    Clin Nephrol; 2011 Apr; 75(4):384-8. PubMed ID: 21426895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Review on anti-glomerular basement membrane disease or Goodpasture's syndrome].
    Marques C; Plaisier E; Cacoub P; Cadranel J; Saadoun D
    Rev Med Interne; 2020 Jan; 41(1):14-20. PubMed ID: 31776042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.